14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.23 $9.13 Friday, 3rd May 2024 ARDX stock ended at $8.72. This is 28.42% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 14.41% from a day low at $7.98 to a day high of $9.13.
90 days $6.23 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
Jan 19, 2022 $0.90 $0.92 $0.88 $0.90 3 174 800
Jan 18, 2022 $0.92 $0.92 $0.88 $0.89 3 248 200
Jan 14, 2022 $0.91 $0.94 $0.89 $0.93 2 596 200
Jan 13, 2022 $0.96 $0.99 $0.91 $0.93 4 116 500
Jan 12, 2022 $1.01 $1.02 $0.95 $0.95 3 610 500
Jan 11, 2022 $0.96 $1.03 $0.96 $1.01 1 867 400
Jan 10, 2022 $1.00 $1.02 $0.97 $1.00 3 054 700
Jan 07, 2022 $1.01 $1.03 $0.97 $1.00 2 369 100
Jan 06, 2022 $1.02 $1.04 $0.93 $1.00 4 762 100
Jan 05, 2022 $1.08 $1.12 $1.00 $1.02 5 620 800
Jan 04, 2022 $1.16 $1.18 $1.07 $1.10 5 431 373
Jan 03, 2022 $1.12 $1.20 $1.07 $1.18 6 016 534
Dec 31, 2021 $1.13 $1.18 $1.07 $1.10 3 641 852
Dec 30, 2021 $1.03 $1.22 $1.03 $1.13 8 582 567
Dec 29, 2021 $1.01 $1.08 $0.98 $1.02 7 278 079
Dec 28, 2021 $1.07 $1.14 $1.03 $1.03 6 895 485
Dec 27, 2021 $1.15 $1.16 $1.07 $1.08 10 889 168
Dec 23, 2021 $1.14 $1.25 $1.12 $1.18 9 148 423
Dec 22, 2021 $1.21 $1.21 $1.12 $1.12 11 369 564
Dec 21, 2021 $1.24 $1.26 $1.19 $1.24 8 298 822
Dec 20, 2021 $1.22 $1.29 $1.18 $1.23 8 803 705
Dec 17, 2021 $1.20 $1.28 $1.13 $1.25 9 373 737
Dec 16, 2021 $1.25 $1.26 $1.16 $1.21 7 049 644
Dec 15, 2021 $1.26 $1.26 $1.08 $1.20 15 179 764
Dec 14, 2021 $1.36 $1.36 $1.22 $1.24 14 539 586
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT